In addition to demonstrating the ability of Chk1 and Wee1 inhibition to enhance the radiosensitivity of HNSCC cells towards X-rays, we also show that this strategy can increase the efficacy of PBT at both low and relatively high-LET relative to the Bragg peak. The gene discussed is CHEK1; the disease is head and neck squamous cell carcinoma.